Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3864)
All Articles published online
|
Publishing Process of This Article
|
Feb 6, 2022 (publication date) through Jan 26, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang J, Wang X, Tian JJ, Zhu R, Duo RX, Huang YC, Shen HL. Iguratimod in treatment of primary Sjögren’s syndrome concomitant with autoimmune hemolytic anemia: A case report. World J Clin Cases 2022; 10(4): 1286-1290 [PMID: 35211561 DOI: 10.12998/wjcc.v10.i4.1286] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i4/1286.htm |
| Number | Citing Articles |
| 1 |
Qi Zhang, Xi-Rui Yang, Yao Deng. Iguratimod Alleviates Experimental Sjögren’s Syndrome by Inhibiting NLRP3 Inflammasome Activation. Cell Biochemistry and Biophysics 2024; 82(3): 2275 doi: 10.1007/s12013-024-01337-2
|